This video explains 10 early signs and symptoms of diabetes that often go unnoticed. These include increased thirst, frequent bathroom breaks, recurrent infections, unexplained weight changes, and blurry…
This video dives into Pompe Disease, also known as Glycogen Storage Disease Type 2. The host explains the key components of this disease, where the body cannot break…
NEW YORK (Reuters Health) – The glucagon-like peptide 1 analog taspoglutide administered subcutaneously once weekly improves glycemic control and reduces body weight in drug-naive patients with type 2…
NEW YORK (Reuters Health) – If lifestyle changes are not enough to control type 2 diabetes, metformin should be the first oral agent added to treatment, according to…
NEW YORK (Reuters Health) – Patients with type 2 diabetes who don’t have retinopathy at baseline have a relatively low risk of developing eye complications during 5 to…
NEW YORK (Reuters Health) – Fenofibrate is safe to use in patients with type 2 diabetes and moderate renal impairment, researchers conclude in a report online December 30…
NEW YORK (Reuters Health) – Based on the 2010 American Diabetes Association’s definition of prediabetes, the condition is present in over a third of psychiatric inpatients treated with…
NEW YORK (Reuters Health) – Parental fear of hypoglycemia probably blunts the potential benefits of continuous glucose monitoring in children with type 1 diabetes, researchers conclude in a…
NEW YORK (Reuters Health) – Cirrhosis and hepatitis are associated with the occurrence of hepatocellular carcinoma (HCC) in patients with diabetes, and hepatitis C is of particular importance,…
NEW YORK (Reuters Health) – Although the pharmacokinetics (PK) and pharmacodynamics (PD) of high-dose human regular U-500 and human regular U-100 insulin are similar, the U-500 formulation may…
NEW YORK (Reuters Health) – Insulin resistance shows no significant association with an increased risk of atrial fibrillation, researchers report in an October 14th on-line paper in the…
NEW YORK (Reuters Health) – More intensive blood glucose lowering won’t reduce the risk of heart failure in patients with type 2 diabetes, and when achieved with a…
